PlainRecalls
FDA Drug Low Class III Terminated

Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1

Reported: January 10, 2024 Initiated: December 8, 2023 #D-0213-2024

Product Description

Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.

Details

Units Affected
2,220 bottles
Distribution
USA nationwide.
Location
Wilmington, MA

Frequently Asked Questions

What product was recalled?
Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1. Recalled by Azurity Pharmaceuticals, Inc.. Units affected: 2,220 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 10, 2024. Severity: Low. Recall number: D-0213-2024.